NeuroPaceResponsive neurostimulation for the treatment of epilepsy
About UsProductClinical TrialsResourcesPDMSContact Us


Company Overview

Corporate Officers

News

Careers

Contact



Company Overview

NeuroPace was founded to design, develop, manufacture and market implantable devices for the treatment of neurological disorders by responsive brain stimulation. The company's initial focus is the treatment of epilepsy, a debilitating neurological disorder affecting approximately 1% of the population worldwide. A clinical trial of the company's RNS® System for treating medically refractory epilepsy is ongoing, but not enrolling new participants.

In addition to treating epilepsy, responsive neurostimulation holds the promise of treating several other disabling medical disorders that impact the quality of life for millions of patients around the world.

Located in Mountain View, California, NeuroPace is a privately-held company.